Cargando…
Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study
BACKGROUND & OBJECTIVES: Cirrhosis patients with worsening of the liver function are defined as acute decompensation (AD) and those who develop extrahepatic organ failure are defined as acute-on-chronic liver failure (ACLF). Both AD and ACLF have an extremely poor prognosis. However, information...
Autores principales: | Teerasarntipan, Tongluk, Thanapirom, Kessarin, Chirapongsathorn, Sakkarin, Suttichaimongkol, Tanita, Chamroonkul, Naichaya, Bunchorntavakul, Chalermrat, Siramolpiwat, Sith, Chainuvati, Siwaporn, Sobhonslidsuk, Abhasnee, Leerapun, Apinya, Piratvisuth, Teerha, Sukeepaisarnjaroen, Wattana, Tanwandee, Tawesak, Treeprasertsuk, Sombat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681104/ https://www.ncbi.nlm.nih.gov/pubmed/36413538 http://dx.doi.org/10.1371/journal.pone.0277959 |
Ejemplares similares
-
Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2022) -
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2023) -
Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients
por: Sripongpun, Pimsiri, et al.
Publicado: (2019) -
Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
por: Thanapirom, Kessarin, et al.
Publicado: (2019) -
Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2020)